Endothelin a final common pathway in pathophysiology of PE

Post a reply


In an effort to prevent automatic submissions, we require that you type the text displayed into the field underneath.
Smilies
:D :) ;) :( :o :shock: :? 8-) :lol: :x :P :oops: :cry: :evil: :twisted: :roll: :!: :?: :idea: :arrow: :| :mrgreen: :geek: :ugeek:

BBCode is ON
[img] is ON
[flash] is OFF
[url] is ON
Smilies are ON

Topic review
   

If you wish to attach one or more files enter the details below.

Expand view Topic review: Endothelin a final common pathway in pathophysiology of PE

Endothelin a final common pathway in pathophysiology of PE

Post by caryn » Tue Jan 24, 2012 03:18 pm

Identification of antiangiogenic, autoimmune, and inflammatory factors produced in response to placental ischemia have provided potential new avenues for future research into novel therapies for the preeclamptic patient, and suggest new therapeutic avenues for the treatment of preeclampsia.

http://www.ncbi.nlm.nih.gov/pubmed/22257796

Just another "oh hey, it's likely to be soluble FLT and soluble endoglin triggering a pissed-off maternal immune system after the placenta runs short of blood" abstract. :D

Top